- Home
- Publications
- Publication Search
- Publication Details
Title
Novel drug targets for treatment of cryptosporidiosis
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume -, Issue -, Pages 1-8
Publisher
Informa UK Limited
Online
2020-06-19
DOI
10.1080/14728222.2020.1785432
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clofazimine for treatment of cryptosporidiosis in HIV-infected adults (CRYPTOFAZ): an experimental medicine, randomized, double-blind, placebo-controlled phase 2a trial
- (2020) P Y Iroh Tam et al. CLINICAL INFECTIOUS DISEASES
- Bumped Kinase Inhibitors as therapy for apicomplexan parasitic diseases: lessons learned
- (2020) Ryan Choi et al. INTERNATIONAL JOURNAL FOR PARASITOLOGY
- Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis
- (2019) Beatriz Baragaña et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Piperazine-Derivative MMV665917: an effective drug in the diarrheic piglet model of Cryptosporidium hominis
- (2019) Sangun Lee et al. JOURNAL OF INFECTIOUS DISEASES
- Cryptosporidium parvum subtilisin-like serine protease (SUB1) is crucial for parasite egress from host cells
- (2019) Samantha Nava et al. INFECTION AND IMMUNITY
- Optimization of Methionyl tRNA-Synthetase Inhibitors for Treatment of Cryptosporidium Infection
- (2019) Frederick S. Buckner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The incidence, aetiology, and adverse clinical consequences of less severe diarrhoeal episodes among infants and children residing in low-income and middle-income countries: a 12-month case-control study as a follow-on to the Global Enteric Multicenter Study (GEMS)
- (2019) Karen L Kotloff et al. Lancet Global Health
- A Stem-Cell-Derived Platform Enables Complete Cryptosporidium Development In Vitro and Genetic Tractability
- (2019) Georgia Wilke et al. Cell Host & Microbe
- P-glycoprotein mediated efflux reduces the in vivo efficacy of a therapeutic targeting the gastrointestinal parasite Cryptosporidium
- (2019) Samuel L M Arnold et al. JOURNAL OF INFECTIOUS DISEASES
- Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis
- (2019) Christopher S. Lunde et al. Nature Communications
- Identification of adaptive inhibitors of Cryptosporidium parvum fatty acyl-coenzyme A synthetase isoforms by virtual screening
- (2019) Somdeb Chattopadhyay et al. PARASITOLOGY RESEARCH
- Genetic ablation of purine salvage in Cryptosporidium parvum reveals nucleotide uptake from the host cell
- (2019) Mattie C. Pawlowic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metal-captured inhibition of pre-mRNA processing activity by CPSF3 controls Cryptosporidium infection
- (2019) Christopher Swale et al. Science Translational Medicine
- Systematic gene silencing identified Cryptosporidium nucleoside diphosphate kinase and other molecules as targets for suppression of parasite proliferation in human intestinal cells
- (2019) A. Castellanos-Gonzalez et al. Scientific Reports
- A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box
- (2018) R. S. Jumani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapeutic Efficacy of Bumped Kinase Inhibitor 1369 in a Pig Model of Acute Diarrhea Caused by Cryptosporidium hominis
- (2018) Sangun Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical and microbiologic efficacy of the piperazine-based drug lead MMV665917 in the dairy calf cryptosporidiosis model
- (2018) Erin Stebbins et al. PLoS Neglected Tropical Diseases
- Discovery of ebselen as an inhibitor of Cryptosporidium parvum glucose-6-phosphate isomerase (CpGPI) by high-throughput screening of existing drugs
- (2018) Rana Eltahan et al. International Journal for Parasitology-Drugs and Drug Resistance
- Morbidity, mortality, and long-term consequences associated with diarrhoea from Cryptosporidium infection in children younger than 5 years: a meta-analyses study
- (2018) Ibrahim A Khalil et al. Lancet Global Health
- Atorvastatin repurposing for the treatment of cryptosporidiosis in experimentally immunosuppressed mice
- (2017) Noha Madbouly Taha et al. EXPERIMENTAL PARASITOLOGY
- Advances in bumped kinase inhibitors for human and animal therapy for cryptosporidiosis
- (2017) Matthew A. Hulverson et al. INTERNATIONAL JOURNAL FOR PARASITOLOGY
- Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy
- (2017) Matthew A. Hulverson et al. JOURNAL OF INFECTIOUS DISEASES
- A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis
- (2017) Ujjini H. Manjunatha et al. NATURE
- Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis
- (2017) Vitul Jain et al. STRUCTURE
- A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis
- (2017) Melissa S. Love et al. PLoS Neglected Tropical Diseases
- Cryptosporidium and Toxoplasma Parasites Are Inhibited by a Benzoxaborole Targeting Leucyl-tRNA Synthetase
- (2016) Andrés Palencia et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Novel Calcium-Dependent Kinase Inhibitor, Bumped Kinase Inhibitor 1517, Cures Cryptosporidiosis in Immunosuppressed Mice
- (2016) Alejandro Castellanos-Gonzalez et al. JOURNAL OF INFECTIOUS DISEASES
- Novel Bumped Kinase Inhibitors Are Safe and Effective Therapeutics in the Calf Clinical Model for Cryptosporidiosis
- (2016) Deborah A. Schaefer et al. JOURNAL OF INFECTIOUS DISEASES
- Addressing Cryptosporidium Infection among Young Children in Low-Income Settings: The Crucial Role of New and Existing Drugs for Reducing Morbidity and Mortality
- (2016) David A. Shoultz et al. PLoS Neglected Tropical Diseases
- The Burden of Cryptosporidium Diarrheal Disease among Children < 24 Months of Age in Moderate/High Mortality Regions of Sub-Saharan Africa and South Asia, Utilizing Data from the Global Enteric Multicenter Study (GEMS)
- (2016) Samba O. Sow et al. PLoS Neglected Tropical Diseases
- Cryptosporidiosis Drug Discovery: Opportunities and Challenges
- (2016) Ujjini H. Manjunatha et al. ACS Infectious Diseases
- Target validation of the inosine monophosphate dehydrogenase (IMPDH) gene in Cryptosporidium using Phylomer® peptides
- (2015) R. Jefferies et al. EXPERIMENTAL PARASITOLOGY
- Differential Gene Expression and Protein Localization ofCryptosporidium parvumFatty Acyl-CoA Synthetase Isoforms
- (2015) Fengguang Guo et al. JOURNAL OF EUKARYOTIC MICROBIOLOGY
- A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium
- (2015) William Checkley et al. LANCET INFECTIOUS DISEASES
- A Proposed Target Product Profile and Developmental Cascade for New Cryptosporidiosis Treatments
- (2015) Christopher D. Huston et al. PLoS Neglected Tropical Diseases
- Oleylphosphocholine (OlPC) arrests Cryptosporidium parvum growth in vitro and prevents lethal infection in interferon gamma receptor knock-out mice
- (2015) Karine Sonzogni-Desautels et al. Frontiers in Microbiology
- Structural studies provide clues for analog design of specific inhibitors of Cryptosporidium hominis thymidylate synthase–dihydrofolate reductase
- (2014) Vidya P. Kumar et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A novel CDPK1 inhibitor—a potential treatment for cryptosporidiosis in calves?
- (2014) Matthias Lendner et al. PARASITOLOGY RESEARCH
- Direct Comparison of the Efficacy and Safety of Oral Treatments with Oleylphosphocholine (OlPC) and Miltefosine in a Mouse Model of L. major Cutaneous Leishmaniasis
- (2014) Anny Fortin et al. PLoS Neglected Tropical Diseases
- Validation of IMP Dehydrogenase Inhibitors in a Mouse Model of Cryptosporidiosis
- (2013) Suresh Kumar Gorla et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Cysteine Protease Inhibitor Rescues Mice from a Lethal Cryptosporidium parvum Infection
- (2013) Momar Ndao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Drug Repurposing Screen Reveals FDA-Approved Inhibitors of Human HMG-CoA Reductase and Isoprenoid Synthesis That Block Cryptosporidium parvum Growth
- (2013) Kovi Bessoff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Amelioration of Cryptosporidium parvum Infection In Vitro and In Vivo by Targeting Parasite Fatty Acyl-Coenzyme A Synthetases
- (2013) F. Guo et al. JOURNAL OF INFECTIOUS DISEASES
- Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study
- (2013) Karen L Kotloff et al. LANCET
- Targeting Plasmodium PI(4)K to eliminate malaria
- (2013) Case W. McNamara et al. NATURE
- Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis
- (2012) T. P. C. Dorlo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In a trial of the use of miltefosine to treat HIV‐related cryptosporidiosis in Zambian adults, extreme metabolic disturbances contribute to high mortality
- (2011) E Sinkala et al. ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY
- Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors
- (2010) Kayode K Ojo et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Discovery of Potent and Selective Inhibitors of CDPK1 from C. parvum and T. gondii
- (2010) Ryan C. Murphy et al. ACS Medicinal Chemistry Letters
- Cryptopain-1, a cysteine protease of Cryptosporidium parvum, does not require the pro-domain for folding
- (2008) B.-K. NA et al. PARASITOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now